Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Clinical trial NCT04466098 · COMPLETED

Trial details

NCT number: NCT04466098
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome ARDS (Moderate or Severe)COVID-19 Pneumonia

Start date: 2020-07-30
Primary completion: 2022-02-25
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.